Ornidazole is an antimicrobial molecule from the nitroimidazole class. It was developed to combat infections caused by anaerobic bacteria and protozoa, organisms that thrive in low or no-oxygen environments. Its clinical importance grew due to strong activity against pathogens responsible for intestinal, gynecologic, dental, and liver-based infections. The molecule entered medical use in global markets in the early 1970s after completing clinical safety and efficacy evaluations. It was later widely adopted across countries for the treatment of amoebiasis, giardiasis, trichomoniasis, and anaerobic bacterial infections.

Ornidazole uses for the treatment of : 

• Gastrointestinal infections caused by Giardia, Entamoeba histolytica, and anaerobic bacteria

• Bacterial vaginosis and pelvic infections

• Liver abscesses due to anaerobic bacteria.

• Skin and soft tissue infections caused by anaerobes

• Prevention of infections following surgical procedures

• Oral tablets or suspension for outpatient treatment.

• Intravenous infusion for hospital-based infection care or when oral therapy is not feasible.

• Typical dosing frequency is once or twice daily, depending on infection type and severity.

• IV formulations are infused slowly using compatible fluids under clinical supervision.

• Therapy duration is usually short-term, commonly 3 to 10 days based on infection and clinical response.

Common Ornida Infusion side effects include:

• Nausea and vomiting

• Stomach pain or diarrhoea

• Headache

• Metallic taste in the mouth
  

Less common side effects:

• Dizziness or vertigo

• Skin rash or itching

• Neurological effects such as numbness or tingling in extremities (rare)

Seek medical attention if severe neurological symptoms, allergic reactions, or persistent gastrointestinal issues occur.

• Can cause nervous system-related symptoms such as dizziness, sleepiness, tremors, or rarely seizures in sensitive individuals.

• Avoid alcohol during treatment, as reactions like flushing, nausea, vomiting or rapid heartbeat may occur.

• Use carefully if there is a history of neurological disorders, including peripheral neuropathy or epilepsy related conditions.

• May occasionally lead to blood cell count changes, so monitoring is advised when treatment is prolonged.

• Hypersensitivity reactions are possible; stop use if symptoms like rash, swelling or breathing difficulty appear.

• Assess carefully in those with liver disease, as metabolism occurs mainly through hepatic pathways.

• Monitor patients who develop tingling, numbness or muscle coordination issues and discontinue if symptoms persist.

• Caution in elderly patients or those on CNS-acting medications due to additive neurological effects such as drowsiness.

• Ensure adequate hydration during treatment for parasitic intestinal infections.

• Use in pregnancy or breastfeeding only when medically advised and clearly needed.

• Not routinely recommended for long-term therapy unless absolutely required with blood parameter checks.

• Take the medicine at the same time each day for best results.

• Maintain adequate hydration and balanced nutrition while taking Ornidazole.

• Avoid alcohol completely during treatment.

• Do not skip doses or stop therapy early, even if symptoms improve.

• Consult your doctor immediately if any severe side effects occur.

1. https://go.drugbank.com/drugs/DB13026

2. https://www.sciencedirect.com/topics/neuroscience/ornidazole

3. https://precision.fda.gov/ginas/app/ui/substances/6ff13aa2-0a8b-4188-a5d9-e15514fddabe

The drug information on this page is not a substitute for medical advice. It is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you can receive this treatment.